Paul Retif - Search Results

Year	Number of Results
2011	1
2015	1
2016	2
2019	1
2021	5
2022	0

1

Cranial organs at risk delineation: heterogenous practices in radiotherapy planning.

Vogin G, Hettal L, Bartau C, Thariat J, Claeys MV, Peyraga G, Retif P, Schick U, Antoni D, Bodgal Z, Dhermain F, Feuvret L. Vogin G, et al. Among authors: retif p. Radiat Oncol. 2021 Feb 4;16(1):26. doi: 10.1186/s13014-021-01756-y. Radiat Oncol. 2021. PMID: 33541394 Free PMC article.

2

Nanoparticles for Radiation Therapy Enhancement: the Key Parameters.

Retif P, Pinel S, Toussaint M, Frochot C, Chouikrat R, Bastogne T, Barberi-Heyob M. Retif P, et al. Theranostics. 2015 Jun 11;5(9):1030-44. doi: 10.7150/thno.11642. eCollection 2015. Theranostics. 2015. PMID: 26155318 Free PMC article. Review.

3

Technical Note: A 3D-printed phantom for radiochromic film evaluation of moving lung tumor SBRT without dose convolution.

Retif P, Djibo Sidikou A, Letellier R, Verrecchia-Ramos E, Quetin P. Retif P, et al. Med Phys. 2021 Jul;48(7):3453-3458. doi: 10.1002/mp.14841. Epub 2021 Jul 7. Med Phys. 2021. PMID: 33720419

4

Prospective validation of stringent dose constraints for prostatic stereotactic radiation monotherapy: results of a single-arm phase II toxicity-oriented trial.

Nguyen P, Harzée L, Retif P, Joseph S, Vogin G, Nickers P. Nguyen P, et al. Among authors: retif p. Strahlenther Onkol. 2021 Nov;197(11):1001-1009. doi: 10.1007/s00066-021-01832-y. Epub 2021 Aug 23. Strahlenther Onkol. 2021. PMID: 34424351 Clinical Trial.

5

Innovative procedure for measuring left ventricular ejection fraction from ¹⁸F-FDG first-pass ultra-sensitive digital PET/CT images: evaluation with an anthropomorphic heart phantom.

Verrecchia-Ramos E, Morel O, Retif P, Ben Mahmoud S. Verrecchia-Ramos E, et al. Among authors: retif p. EJNMMI Phys. 2021 May 20;8(1):42. doi: 10.1186/s40658-021-00387-2. EJNMMI Phys. 2021. PMID: 34018067 Free PMC article.

6

Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.

Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, Roux PE, Poupart M, Vogin G, Foray N, Pereira S. Deneuve S, et al. Among authors: retif p. Cancers (Basel). 2021 May 19;13(10):2477. doi: 10.3390/cancers13102477. Cancers (Basel). 2021. PMID: 34069662 Free PMC article.

7

Robustness Analysis of a Geant4-GATE Simulator for Nanoradiosensitizers Characterization.

Retif P, Bastogne T, Barberi-Heyob M. Retif P, et al. IEEE Trans Nanobioscience. 2016 Apr;15(3):209-17. doi: 10.1109/TNB.2016.2527720. Epub 2016 Feb 11. IEEE Trans Nanobioscience. 2016. PMID: 26887000

8

Radiation-Induced Mitotic Catastrophe Enhanced by Gold Nanoparticles: Assessment with a Specific Automated Image Processing Workflow.

Paquot H, Daouk J, Chateau A, Rétif P, Barberi-Heyob M, Pinela S. Paquot H, et al. Among authors: retif p. Radiat Res. 2019 Jul;192(1):13-22. doi: 10.1667/RR14962.1. Epub 2019 Apr 25. Radiat Res. 2019. PMID: 31021734

9

Monte Carlo simulations guided by imaging to predict the in vitro ranking of radiosensitizing nanoparticles.

Retif P, Reinhard A, Paquot H, Jouan-Hureaux V, Chateau A, Sancey L, Barberi-Heyob M, Pinel S, Bastogne T. Retif P, et al. Int J Nanomedicine. 2016 Nov 18;11:6169-6179. doi: 10.2147/IJN.S111320. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27920524 Free PMC article.

10

Quality assessment of fluorodeoxyglucose positron emission tomography imaging in clinical setting: definition of standard quality control parameters for patients treated for lymphoma.

Retif P, Jegouic C, Slosman DO. Retif P, et al. Nucl Med Commun. 2011 Sep;32(9):794-801. doi: 10.1097/MNM.0b013e328347e5b8. Nucl Med Commun. 2011. PMID: 21685822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results